Humana down after Morgan Stanley downgrades to 'underweight'

Shares of health insurance company Humana HUM.N down 2.4% at $190.50 premarket

Morgan Stanley downgrades to "underweight" from "equal weight"; cuts PT to $174 from $262

New PT represents an 11% downside to stock's last close

"HUM's 2026 bid strategy alongside incremental policy risk on the back of an unfavorable Advance Rate Notice may slow co's progress on its multi-year turnaround strategy" - Brokerage

Adds that co may pick up more members than planned as competitors see larger‑than‑expected MA (Medicare Advantage) enrollment declines, but unexpected growth could strain profitability and complicate its turnaround plan

8 of 28 brokerages rate stock "buy" or higher, 19 "hold" and 1 "sell"; median PT is $288 - data compiled by LSEG

CPRI gained ~1% in 2025